These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3237760)

  • 1. Mechanism of action of the anti-shock effect of CCK-8: influence of CCK antagonists and of sympatholytic drugs.
    Guarini S; Vergoni AV; Bertolini A
    Pharmacology; 1988; 37(5):286-92. PubMed ID: 3237760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haematological changes induced by the intravenous injection of CCK-8 in rats subjected to haemorrhagic shock.
    Guarini S; Bazzani C; Leo L; Bertolini A
    Neuropeptides; 1988; 11(2):69-72. PubMed ID: 3368038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caerulein and cholecystokinin reverse experimental hemorrhagic shock.
    Bertolini A; Guarini S; Ferrari W; Rompianesi E
    Neuropeptides; 1986 Jul; 8(1):25-31. PubMed ID: 3762876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of cholecystokinin octapeptide and food intake in male rats treated with cholecystokinin octapeptide.
    Lindén A; Uvnäs-Moberg K; Forsberg G; Bednar I; Södersten P
    J Endocrinol; 1989 Apr; 121(1):59-65. PubMed ID: 2565947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the sympathetic nervous system in the cardiovascular effects of ACTH-(1-24) during hemorrhagic shock in rats.
    Guarini S; Ferrari W; Bertolini A
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):556-60. PubMed ID: 3412492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antagonistic effect of cholecystokinin octapeptide (CCK-8) on opioid effects in cardiovascular activities was mediated by CCK-B receptor.
    Mei L; Han JS
    Sci China B; 1993 Jul; 36(7):817-23. PubMed ID: 8216742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
    Katsuura G; Hsiao S; Itoh S
    Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone.
    Kamilaris TC; Johnson EO; Calogero AE; Kalogeras KT; Bernardini R; Chrousos GP; Gold PW
    Endocrinology; 1992 Apr; 130(4):1764-74. PubMed ID: 1312423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different cholinergic pathways are involved in the improvement induced by CCK-8 and by ACTH-(1-24) in massive acute hemorrhage, in rats.
    Guarini S; Bertolini A; Lancellotti N; Rompianesi E; Ferrari W
    Pharmacol Res Commun; 1987 Jul; 19(7):511-6. PubMed ID: 3671437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
    J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
    Millington WR; Mueller GP; Lavigne GJ
    J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral and central cholecystokinin receptors regulate postprandial intestinal motility in the rat.
    Rodríguez-Membrilla A; Martínez V; Vergara P
    J Pharmacol Exp Ther; 1995 Oct; 275(1):486-93. PubMed ID: 7562590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin octapeptide improves cardiac function by activating cholecystokinin octapeptide receptor in endotoxic shock rats.
    Zhao XY; Ling YL; Li YG; Meng AH; Xing HY
    World J Gastroenterol; 2005 Jun; 11(22):3405-10. PubMed ID: 15948246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of CCK1 receptors to cardiovascular and respiratory effects of cholecystokinin in anesthetized rats.
    Kaczyńska K; Szereda-Przestaszewska M
    Neuropeptides; 2015 Dec; 54():29-34. PubMed ID: 26342277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin-dopamine receptor interactions as studied with cholecystokinin receptor antagonists.
    Murphy RB
    Prog Clin Biol Res; 1985; 192():105-13. PubMed ID: 3001746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats.
    Makovec F; Bani M; Chistè R; Revel L; Rovati LC; Setnikar I
    Regul Pept; 1986 Dec; 16(3-4):281-90. PubMed ID: 3562900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
    Li Y; Hao Y; Owyang C
    Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide.
    Tanimoto K; Tamminga CA; Chase TN; Nilaver G
    Endocrinology; 1987 Jul; 121(1):127-32. PubMed ID: 3297634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential antagonism by proglumide of various CCK-mediated effects in mice.
    Barbaz BS; Autry WL; Ambrose FG; Gerber R; Liebman JM
    Prog Clin Biol Res; 1985; 192():151-8. PubMed ID: 4080708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.